Skip to main navigation Skip to search Skip to main content

Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials

  • G. B. Klintmalm*
  • , F. Vincenti
  • , A. Kirk
  • *Corresponding author for this work

Research output: Contribution to journalEditorial

10 Scopus citations
Original languageEnglish
Pages (from-to)3077-3078
Number of pages2
JournalAmerican Journal of Transplantation
Volume16
Issue number11
DOIs
StatePublished - 1 Nov 2016
Externally publishedYes

Keywords

  • clinical trial design
  • editorial/personal viewpoint
  • guidelines
  • immunosuppressant
  • immunosuppression/immune modulation

Cite this